Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jieyu Xing"'
Autor:
Haiyun Chen, Yuhan Zeng, Dan Wang, Yichen Li, Jieyu Xing, Yuejia Zeng, Zheng Liu, Xinhua Zhou, Hui Fan
Publikováno v:
Molecules, Vol 29, Iss 7, p 1478 (2024)
Alzheimer’s disease (AD) is a complex degenerative disease of the central nervous system that is clinically characterized by a progressive decline in memory and cognitive function. The pathogenesis of AD is intricate and not yet fully understood. N
Externí odkaz:
https://doaj.org/article/07b3b28201f24d04be3e67e8b85c55bd
Autor:
Jieyu Xing, Limin Lin, Jing Li, Jiayu Liu, Changhua Zhou, Haitao Pan, Rui Shu, Bin Dong, Donglin Cao, Qing Li, Zhong Wang
Publikováno v:
Translational Oncology, Vol 10, Iss 5, Pp 780-785 (2017)
Among different cancer immunotherapy approaches, bispecific antibodies (BsAbs) are of great interest due to their ability to recruit immune cells to kill tumor cells directly. Various BsAbs against Her2 tumor cells have been proposed with potent cyto
Externí odkaz:
https://doaj.org/article/62d5972ac1e24d17a0eb47bdf8eeb717
Autor:
Zhaohui Shu, Jingyun Feng, Lanting Liu, Yingqin Liao, Yuhong Cao, Zhenhua Zeng, Qiuju Huang, Zhonghong Li, Guifang Jin, Zhicheng Yang, Jieyu Xing, Sigui Zhou
Publikováno v:
Journal of Cardiovascular Pharmacology; May2024, Vol. 83 Issue 5, p410-432, 23p
Autor:
Haitao Pan, Jiayu Liu, Zhong Wang, Jing Li, Donglin Cao, Limin Lin, Changhua Zhou, Rui Shu, Bin Dong, Qing Li, Jieyu Xing
Publikováno v:
Translational Oncology, Vol 10, Iss 5, Pp 780-785 (2017)
Among different cancer immunotherapy approaches, bispecific antibodies (BsAbs) are of great interest due to their ability to recruit immune cells to kill tumor cells directly. Various BsAbs against Her2 tumor cells have been proposed with potent cyto
Publikováno v:
Drug Design, Development and Therapy
Yue Liu,1,2 Yanlan Wang,1,2 Jieyu Xing,1,2 Yumei Li,1,2 Jiayu Liu,1,2 Zhong Wang1,2 1School of Pharmaceutical Sciences, 2Center for Cellular and Structural Biology, Sun Yat-Sen University, Guangzhou, People’s Republic of China Introduction: Interle
Publikováno v:
J Vis Exp
This protocol describes the construction and functional studies of a bispecific antibody (bsAb), GPC3-S-Fab. bsAbs can recognize two different epitopes through their two different arms. bsAbs have been actively studied for their ability to directly r
Publikováno v:
International Journal of Nanomedicine
Haitao Pan,1,2 Jiayu Liu,1,2 Wentong Deng,1,2 Jieyu Xing,1,2 Qing Li,1,2 Zhong Wang1,2 1School of Pharmaceutical Sciences, 2Centre for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou, People’s Republic of China Introduction: Bispec
Publikováno v:
Cancer Biology & Therapy. 16:1415-1421
IL-15 has been actively investigated for its potential in tumor immunotherapy. To enhance the anti-tumor activity of IL-15, the novel PFC-1 construct was designed, which comprises the following 3 parts: (1) IL-15Rα fused with IL-15 to enhance IL-15
Publikováno v:
AMB Express
Her2, which is frequently overexpressed in breast cancer, is one of the most studied tumor-associated antigens for cancer therapy. Anti-HER2 monoclonal antibody, trastuzumab, has achieved significant clinical benefits in metastatic breast cancer. In